Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Plus Therapeutics (PSTV) Treasury Shares (2016 - 2025)

Plus Therapeutics has reported Treasury Shares over the past 3 years, most recently at $500000.0 for Q4 2025.

  • Quarterly Treasury Shares changed 0.0% to $500000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $500000.0 through Dec 2025, changed 0.0% year-over-year, with the annual reading at $500000.0 for FY2025, 0.0% changed from the prior year.
  • Treasury Shares was $2.6 million for Q4 2025 at Plus Therapeutics, down from $2.8 million in the prior quarter.
  • Over five years, Treasury Shares peaked at $2.8 million in Q3 2025 and troughed at -$258425.0 in Q1 2024.
  • The 3-year median for Treasury Shares is -$258425.0 (2024), against an average of $483242.9.
  • Year-over-year, Treasury Shares soared 296.83% in 2024 and then changed 0.0% in 2025.
  • A 3-year view of Treasury Shares shows it stood at $126000.0 in 2023, then soared by 296.83% to $500000.0 in 2024, then changed by 0.0% to $500000.0 in 2025.
  • Per Business Quant, the three most recent readings for PSTV's Treasury Shares are $500000.0 (Q4 2025), $500000.0 (Q3 2025), and $500000.0 (Q2 2025).